School of Medicine
Showing 1-10 of 786 Results
-
Saverio La Francesca
Clinical Assistant Professor, Cardiothoracic Surgery
BioClinical Focus
-Heart Transplantation.
-Lung Transplantation
-Organ Perfusion and Preservation.
-Regenerative Medicine
Academic Appointments
-Clinical Assistant Professor, Cardiothoracic Surgery. Current
-Asst. Professor of Surgery. Ohio State University. Wexner Medical Center. Columbus-Ohio. 2019 – 2020
-Staff - Department of Cardiovascular Surgery DeBakey Heart and Vascular Center. Houston, Texas. 2010-2013
-Attending Surgeon - Department of Cardiopulmonary Transplantation. Texas Heart Institute at St. Luke’s Episcopal Hospital. Houston, Texas. 2018- 2010
Industry Experience
-President and Chief Medical Officer, Mar 2017 to Oct 2017 Biostage, Inc. (NASDAQ: BSTG)
-Executive Vice-President and Chief Medical Officer, Aug 2015 to Mar 2017 Biostage, Inc. (NASDAQ: BSTG)
-Chief Medical Officer, Apr 2014 to Jul 2015 Biostage, Inc. (NASDAQ: BSTG) (formerly Harvard Apparatus Regenerative Technology, -
Angelle Desiree LaBeaud
Professor of Pediatrics (Infectious Diseases), Senior Fellow at the Woods Institute for the Environment and Professor, by courtesy, of Epidemiology and Population Health
Current Research and Scholarly InterestsArthropod-borne viruses are emerging and re-emerging infections that are spreading throughout the world. Our laboratory investigates the epidemiology of arboviral infections, focusing on the burden of disease and the long-term complications on human health. In particular, Dr. LaBeaud investigates dengue, chikungunya, and Rift Valley fever viruses in Kenya, where outbreaks cause fever, arthritis, retinitis, encephalitis, and hemorrhagic fever. Our main research questions focus on the risk factors for arboviral infections, the development of diagnostic tests that can be administered in the field to quickly determine what kind of arboviral infection a person has, and the genetic and immunologic investigation of why different people respond differently to the same infection. Our long-term goals are to contribute to a deeper understanding of arboviral infections and their long-term health consequences and to optimize control strategies to prevent these emerging infections. Our laboratory also investigates the effects of antenatal and postnatal parasitic infections on vaccine responses, growth, and development of Kenyan children.
My lab at Stanford supports the field work that is ongoing in Kenya, but we also have several projects that are based locally. We strive to improve diagnostics of arboviral infections and are using Luminex technology to build a new screening assay. We also have created a Luminex based platform to assess vaccine responses against multiple pathogens. -
Norman J. Lacayo, MD
Associate Professor of Pediatrics (Hematology and Oncology)
Current Research and Scholarly InterestsPediatric Hematology/Oncology, Phase I drug studies for refractory and relapsed leukemia; genomic studies, biologic risk-stratification and treatment of acute myeloid leukemia; prediction or induction response and risk of relapse using phosphoproteomics in childhood AML; novel MRD techniques in childhood ALL.